Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma

Journal of Neurocytology

Volumn 32, Issue 3, 2003, Pages 265-276

  Rosenbluth, Jack ^a   Schiff, Rolf ^a   Liang, Wei Lan ^a   Dou, Wenkai ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; MYELIN; SULFATIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; FEMALE; HOST; HYBRIDOMA; MALE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; REMYELINIZATION; SPINAL CORD LESION; STEM CELL;

ANIMALS; ANIMALS, NEWBORN; AUTOANTIBODIES; AXONS; CELL MOVEMENT; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FEMALE; GRAFT SURVIVAL; HYBRIDOMAS; IMMUNOGLOBULIN M; MALE; MICE; MICROSCOPY, ELECTRON; MYELIN SHEATH; OLIGODENDROGLIA; RATS; RATS, WISTAR; REGENERATION; SPINAL CORD; STEM CELLS; SULFOGLYCOSPHINGOLIPIDS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 1042267969     PISSN: 03004864     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEUR.0000010085.91976.a6     Document Type: Article

References (35)

1. ABRAMSKY, O., LISAK, R. P., SILBERBERG, D. H. & PLEASURE, D. E. (1977) Antibodies to oligodendroglia in patients with multiple sclerosis. New England Journal of Medicine 297, 1207-1211.
2. BANSAL, R., WARRINGTON, A. E., GARD, A. L., RANSCHT, B. & PFEIFFER, S. E. (1989) Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. Journal of Neuroscience Research 24, 548-557.
3. BORNSTEIN, M. B. & RAINE, C. S. (1976) The initial structural lesion in serum-induced demyelination in vitro. Laboratory Investigation 35, 391-401.
4. BOSTOCK, H. & SEARS, T. S. (1978) The internodal axon membrane: Electrical excitability and continuous conduction in segmental demyelination. Journal of Physiology (London) 280, 273-301.
5. COMPSTON, D. A., MORGAN, B. P., CAMPBELL, A. K., WILKINS, P., COLE, G., THOMAS, N. D. & JASANI, B. (1989) Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathology and Applied Neurobiology 15, 307-316.
6. DUGANDZIJA-NOVAKOVIC, S., KOSZOWSKI, A. G., LEVINSON, S. R. & SHRAGER, P. (1995) Clustering of Na+ channels and node of Ranvier formation in remyelinating axons. Journal of Neuroscience 15, 492-503.
7. FRANKLIN, R., GILSON, J. M. & BLAKEMORE, W. F. (1997) Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system. Journal of Neuroscience Research 50, 337-344.
8. FRICK, E. & STICKL, H. (1976) The pathogenesis of multiple sclerosis. Cytotoxic antibodies against myelin sheath tissue in multiple sclerosis. Fortschrift für Medizin 94, 1019-1024.
9. HARTUNG, H. P. & RIECKMANN, P. (1997) Pathogenesis of immune-mediated demyelination in the CNS. Journal of Neural Transmission Suppl. 50, 173-181.
10. HILLE, B. (2001) Ion Channels of Excitable Membranes, 3rd edition pp. 456-457. Sinauer: Sunderland.
11. KEIRSTEAD, H. S., HUGHES, H. C. & BLAKEMORE, W. F. (1998) A quantifiable model of axonal regeneration in the demyelinated adult rat spinal cord. Experimental Neurology 151, 303-313.
12. KOJIMA, K., WEKERLE, H., LASSMANN, H., BERGER, T. & LININGTON, C. (1997) Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, S100 beta. Journal of Neural Transmission Suppl. 49, 43-51.
13. KOLES, Z. J. & RASMINSKY, M. (1972) A computer simulation of conduction in demyelinated nerve fibres. Journal of Physiology (London) 227, 351-364.
14. LANG, E. & ROSENBLUTH, J. (2003) Role of myelination in the development of a uniform olivocerebellar conduction time. Journal of Neurophysiology 89, 2259-2270.
15. LASSMANN, H., BRUNNER, C., BRADL, M. & LININGTON, C. (1988) Experimental allergic encephalomyelitis: The balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathologica (Berlin) 2, 566-576.
16. LININGTON, C. & LASSMANN, H. (1989) Immunohistochemical localization of terminal complement complex C9 in EAE. Acta Neuropathologica (Berlin) 79, 78-85.
17. OZAWA, K., SAIDA, T., SAIDA, K., NISHITANI, H. & KAMEYAMA, M. (1989) In vivo CNS demyelination mediated by anti-galactocerebroside antibody. Acta Neuropathologica (Berlin) 7, 621-628.
18. PETERS, A., PALAY, S. L. & WEBSTER, H. deF. (1991) The Fine Structure of the Nervous System, 3rd edition, pp. 262-265. New York: Oxford.
19. PIDDLESDEN, S., LASSMANN, H., ZIMPRICH, F., MORGAN, B. P. & LININGTON, C. (1993) The demyelinating potential of antibodies to myelin oligodendrocyte protein is related to their ability to fix complement. American Journal of Pathology 143, 555-564.
20. PRINEAS, J. W. (1985) The neuropathology of multiple sclerosis. In Handbook of Clinical Neurology. Vol. 3, Demyelinating Diseases. (edited by KOESTER, J. C.) pp. 213-257. New York: Elsevier.
21. RAINE, C. S. & CROSS, A. H. (1989) Axonal dystrophy as a consequence of long-term demyelination. Laboratory Investigation 60, 714-725.
22. RANSCHT, B., WOOD, P. M. & BUNGE, R. P. (1987) Inhibition of in vitro peripheral myelin formation by monoclonal anti-galactocerebroside. Journal of Neuroscience 7, 2936-2947.
23. ROSENBLUTH, J., LIU, Z., GUO, D. & SCHIFF, R. (1994) Inhibition of CNS myelin development in vivo by implantation of anti-GalC hybridoma cells. Journal of Neurocytology 23, 699-707.
24. ROSENBLUTH, J. & MOON, D. (2002) Dysmyelnation induced in vitro by IgM antisulfatide and antigalactocerebroside monoclonal antibodies. Journal of Neuroscience Research 71, 104-109.
25. ROSENBLUTH, J., SCHIFF, R., LIANG, W. L., DOU, W. K. & MOON, D. (1999) Antibody-mediated demyelination: Focal spinal cord lesions induced by implantation of an IgM antigalacterocerebroside-secreting hybridoma. Journal of Neurocytology 28, 397-416.
26. SAIDA, T., SAIDA, K. & SILBERBERG, D. H. (1979) Demyelination produced by exprimental allergic neuritis serum and anti-galactocerebroside antiserum in CNS cultures. An ultrastructural study. Acta Neuropathologica (Berlin) 48, 19-25.
27. SCHIFF, R., ROSENBLUTH, J., DOU, W. K., LIANG, W. L. & MOON, D. (2002) Distribution and morphology of transgenic mouse oligodendroglial-lineage cells following transplantation into normal and myelin-deficient rat CNS. Journal of Comparative Neurology 446, 46-57.
28. 2+ influx pathways in astrocytes and oligodendrocytes: Relationship to the mechanism of myelin repair. Molecular and Cellular Neuroscience 22, 14-24.
29. SOMMER, I. & SCHACHNER, M. (1981) Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Developmental Biology 83, 311-327.
30. STORCH, M. K., PIDDLESDEN, S., HALTIA, M., LIVANAINEN, M., MORGAN, P. & LASSMANN, H. (1998) Multiple sclerosis: In situ evidence for antibody-and complement-mediated demyelination. Annals of Neurology 43, 465-476.
31. 2+ influx during anoxia in mammalian central nervous system white matter. Annals of Neurology 30, 375-380.
32. TAO-CHENG, J. H. & ROSENBLUTH, J. (1982) Development of nodal and paranodal membrane specializations in amphibian peripheral nerves. Brain Research 255, 577-594.
33. TRAPP, B. D., PETERSON, B. S., RANSOHOFF, R. M., RUDICK, R., MORK, S. & BO, L. (1998) Axonal transection in the lesions of multiple sclerosis. New England Journal of Medicine 338, 278-285.
34. WAXMAN S. G. (1977) Conduction in myelinated, unmyelinated and demyelinated fibers. Archives of Neurology 34, 585-589.
35. YOUNG, W., ROSENBLUTH, J., WOJAK, J. C., SAKATANI, K. & KIM, H. (1989) Extracellular potassium activity and axonal conduction in spinal cord of the myelin-deficient mutant rat. Experimental Neurology 106, 41-51.